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Abstract
Objectives Cerebral blood flow (CBF) estimates from arterial spin labelling (ASL) show unexplained variability in older
populations. We studied the impact of variation of haematocrit (Hct) on CBF estimates in a tri-ethnic elderly population.
Materials and methods Approval for the study was obtained from the Fulham Research Ethics Committee and participants gave
written informed consent. Pseudo-continuous arterial spin labelling was performed on 493 subjects (age 55–90) from a tri-ethnic
community-based cohort recruited in London. CBF was estimated using a simplified Buxton equation, with and without
correction for Hct measured from blood samples. Differences in perfusion were compared, stratified by sex, ethnicity and
diabetes. Results of Student’s t tests were reported with effect size.
Results Hct adjustment decreased CBF estimates in all categories except white European men. The decrease for women was 2.7
(3.0, 2.4) mL/100 g/min) (mean (95% confidence interval (CI)), p < 0.001 d = 0.38. The effect size differed by ethnicity with
estimated mean perfusion in South Asian and African Caribbean women found to be lower by 3.0 (3.6, 2.5) mL/100 g/min,
p < 0.001 d = 0.56 and 3.1 (3.6, 2.5) mL/100 g/min), p < 0.001 d = 0.48, respectively. Estimates of perfusion in subjects with
diabetes decreased by 1.8 (2.3, 1.4) mL/100 g/min, p < 0.001 d = 0.23) following Hct correction. Correction for individual Hct
altered sample frequency distributions of CBF values, especially in women of non-European ethnicity.
Conclusion ASL-derived CBF values in women, non-European ethnicities and individuals with diabetes are overestimated if
calculations are not appropriately adjusted for individual Hct.
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Key Points
• CBF quantification from ASL using a fixed Hct of 43.5%, as recommended in the ISMRM white paper, may lead to erroneous
CBF estimations particularly in non-European and female subjects.
• Individually measured Hct values improve the accuracy of CBF estimation and, if these are not available, an adjusted value
according to gender, ethnicity or diabetes status should be considered.
•Hct-corrected ASL could be potentially important for CBF threshold decision making in the fields of neurodegenerative disease
and neuro-oncology.
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Abbreviations
ASL Arterial spin labelling
BMI Body mass index
CBF Cerebral blood flow
CMRO2 Cerebral metabolic rate of oxygen
HbA1c Haemoglobin A1c (glycated
haemoglobin)
Hct Haematocrit
HDL cholesterol High-density lipoprotein cholesterol
LDL cholesterol Low-density lipoprotein cholesterol
PCASL Pseudo-continuous arterial spin labelling
PLD Post-labelling delay
PVC Partial volume correction
Introduction
Arterial spin labelling (ASL) is a magnetic resonance imaging
(MRI) technique increasingly used in research and clinical
settings to calculate cerebral blood flow (CBF) non-
invasively [1]. It has been recognised that ASL can provide
an early biomarker for dementia, cognitive decline and small
vessel disease [2–8]. Despite statistical differences between
groups, e.g. Alzheimer’s disease, mild cognitive impairment
and normal ageing, clinical applications have been hampered
by unexplained inter-subject variability [9, 10].
Deriving quantitative perfusion values from the raw
MRI signal requires the application of a model containing
several assumptions that relate to physiological properties
of the blood and tissues. The white paper recommendations
of the International Society for Magnetic Resonance in
Medicine (ISMRM) and the European Consortium for
ASL in Dementia propose pseudo-continuous ASL
(PCASL) with a single post-labelling delay (PLD) and
slice-timing correction, and the application of a simplified
Buxton equation for quantification of CBF [11, 12]. In this
model, 1650 ms is recommended as the longitudinal relax-
ation time of blood (T1blood) at 3 T. This has been derived
from a linear relationship between haematocrit (Hct) and
blood T1 found in experiments under appropriate physio-
logical conditions [13], assuming an average adult Hct of
43.5% [11]. However, there are well-recognised sources of
variation in Hct between and within populations that may
render CBF estimation inaccurate if they are excluded from
the model [9, 10].
Hct varies by sex with females typically having lower Hct
than males [14]. Most studies show a lower Hct in blacks than
Asians comparedwith whites [15, 16], although an earlier study
found this varied according to age and was not applicable in
some younger subjects (men aged 15–24) [17]. Higher Hct
levels have been associated with obesity [14] and have also
been associated with risk of developing diabetes [18].
Diabetic patients with long-standing disease may have de-
creased Hct, possibly due to diabetic nephropathy causing
erythropoietin deficiency [19], or malabsorption of vitamin
B12 as a side-effect of long-term treatment with metformin [20].
The purpose of this study was to identify the variability in
cortical CBF using ASL, to investigate the influence of Hct on
the estimation of CBF and to determine how this impacts on
the associations of CBF with age, sex, ethnicity and diabetes.
Materials and methods
Study population
Subjects (n = 493, 40% female, age range 55–90) were recruit-
ed from the Southall and Brent Revisited (SABRE) study.
Approval for investigations was obtained from the Fulham
Research Ethics Committee (ref: 14/LO/0108) and partici-
pants gave written informed consent. SABRE is a longitudinal
study principally investigating cardio-metabolic disease in a
tri-ethnic population cohort; details have been published else-
where [21]. Briefly, participants were community-dwelling
elderly men and women and resident in the north and north-
west London at the commencement of the SABRE study in
1988. Ethnicity was defined based on the country of origin of
all four grandparents. Spouses or significant others were invit-
ed to participate in a clinical visit, commencing in 2014. An
additional booster sample of African Caribbeans from the
same area of London was recruited to increase numbers and
therefore enhance the power of the study. Data for this study
were acquired between August 2014 and October 2016.
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Investigations
Participants underwent all examinations on the same day as
MRI. Participants were requested to consume nomore than an
early light breakfast prior to arrival at the clinic. Weight and
height were measured using a Tanita Pro BC-418 Body
Composition Analyser and a Seca 216 Stadiometer, respec-
tively, and body mass index (BMI) was calculated. Supine
central blood pressure (BP) and heart rate (HR) were mea-
sured using a Pulsecor device after 5-min rest, in both arms.
BP was calculated as the average of the final two of three
measurements in the left arm unless the difference between
arms was > 10 mmHg in which case the arm with the higher
BP was used. Mean arterial pressure (MAP) was calculated
using a Pulsecor device (www.uscom.com.au) to measure the
arterial pressure waveform during suprasystolic brachial cuff
inflations. Hct was measured using an impedance-based,
direct current sheath flow method (Sysmex XE-2100) from a
venous blood sample drawn on the same morning as the MRI
examination. Blood was also analysed for glycosylated
haemoglobin (HbA1c), serum total cholesterol, high-density
lipoprotein (HDL) cholesterol and triglycerides. Low-density
lipoprotein (LDL) cholesterol was calculated using the
Friedewald equation.
Diabetes mellitus
Diabetes status was determined by the following criteria:
primary care records of diagnosis or prescription of diabe-
tes medication, patient recall of diagnosis or taking antidi-
abetic medication, fasting or oral glucose tolerance test or
plasma glucose testing from previous SABRE study visits
using the WHO recommendations [22] and those with an
HbA1c > 47 mmol/mol when tested in the research clinic.
MRI imaging protocol
All subjects were examined at a single centre, University
College Hospital, on a 3 T MRI (Achieva, Philips
Healthcare) using an 8-channel phased-array head coil. The
protocol included a sagittal T1-weighted 3D-TFE (TR/TE/TI
7/ 3.2/836 ms, flip-angle 18°, voxel size 1 mm3) and a trans-
versal 2D pseudo-continuous arterial spin labelling (PCASL)
(EPI, TR/TE4615/15ms, flip-angle 90°, voxel size 3.75mm×
3.75 mm× 5 mm, 1-mm slice gap, 20 slices), labelling dura-
tion 1800 ms, post-labelling delay 2000 ms, 35 acquisitions, 2
background suppression pulses (1950 ms and 3296 ms after
saturation). There were three repetitions of a proton density–
weighted image with TR = 9000 ms and no background sup-
pression, but otherwise identical parameters as PCASL were
also acquired. Planning was aligned to the anterior
commissure-posterior commissure line in the transversal
plane orthogonal to the T1w sagittal plane, ensuring coverage
of the entire cerebrum including the vertex. The labelling
plane was positioned on a phase-contrast survey to identify
the vessels.
MR segmentation and cerebral blood flow processing
Tissue segmentation and region labels were obtained using the
Geodesic Information Flows framework [23] (https://github.
com/KCL-BMEIS/NiftySeg). This method produces a state-
of-the-art segmentation and regional labelling by voxel-wise
voting between several propagated atlases, guided by the local
image similarity. Grey matter and white matter are defined
within the propagated atlases. Segmentations of the grey mat-
ter, white matter and cerebrospinal fluid space are resampled
to the space of the ASL acquisition making use of the known
point-spread function to account for down-sampling induced
loss of information.
The determination of CBF maps from ASL data followed
the simple derived form for PCASL (Eq. 1) from [11] presented
in units of mL/100 g/min using an open-source in-house soft-
ware package [24] (https://cmiclab.cs.ucl.ac.uk/CMIC/
NiftyFit-Release). Thirty-five control, (SC) and label (SL) pairs
and 5 proton density (SPD) images were averaged to generate
single voxel values for the control and label in Eq. 1, where λ is
the blood/brain partition coefficient (0.9 mL/g), PLD is the
post-labelling delay between the end of bolus and the start of
imaging (2000ms), T1blood is the blood T1 relaxation time,α is
the labelling efficiency (85%) and τ is the labelling duration
(1800 ms). T1blood was calculated based on the formula: T1 =
(0.52 ×Hct + 0.38)−1[13] either with fixed value of 43.5% (cor-
responding to the standard value of T1 = 1650 ms), which was
used in model 1 (CBFfixed), or calculated based on the Hct
values measured from each participant and used in model 2
(CBFHct). The perfusion difference between CBF models using
a fixedHct and individualisedHct was calculated as an absolute
number and as a percentage of the fixed Hct model.
CBF ¼ 6000λ ePLD=T1blood SC–SLð Þ=SPD
2α T1blood 1−e−τ=T1blood
  
mL=100 g=min½ 
ð1Þ
Partial volume correction (PVC) was applied based upon
the method used in [25]. Results for segmented cortical grey
matter PVC CBF are presented. Cortical grey matter CBF
without PVC are presented in supplemental material (Supp
Table 1).
Statistical analysis
Analysis was performed using STATA 14.2 (College Station,
TX). All analyses were stratified by sex and ethnicity.
Continuous data are presented as mean and standard deviation
(SD); categorical data are counts and percentages.
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Paired t tests were used to test for statistical significance be-
tween the twomethods of CBF calculation. Pearson’s correlation
coefficient was computed to quantify the correlations between
Hct and CBF estimates. Comparisons by sex and ethnicity were
performed using two-way analysis of variance (ANOVA),
followed by individual group-wise comparisons using Fisher’s
least significant difference test if ANOVA was significant
(p< 0.05). Multiple linear regression analyses were performed
to assess participant characteristic associations with Hct levels
with further adjustment for potential confounders, age, mean
arterial pressure, diabetes, HbA1C, LDL cholesterol, HDL cho-
lesterol andBMI, chosen a priori. Sample frequency distributions
of CBF calculated with and without correction for individual Hct
were analysed using univariate kernel density estimates.
Results
Five hundred forty-one participants attended MRI. Four hun-
dred ninety-three completed the MRI scan and were success-
fully processed for CBF. Exclusions were due to susceptibility
artefacts such as dental work affecting the radiofrequency label
(n = 12), claustrophobia/inability to tolerate the scan (n = 9),
segmentation processing errors due to excessive head move-
ment (n = 25), pathology (n = 1) and scanner artefact (n = 1).
Participant characteristics
Table 1 shows the basic characteristics of the sample stratified
by sex and ethnicity. The sample comprised 493 individuals of
whom 40% (n = 196) were women. Women were younger
than men (women mean age ± SD, 69.7 ± 6.4 years; men
72.9 ± 5.2 years; p < .001). White Europeans represented
46% of the sample, South Asians 35% and African
Caribbeans 19%. A total of 27% of the participants had type
2 diabetes.
Haematocrit
The mean (SD) Hct of our sample was 41.6% (3.7). This is
lower than the population mean Hct of 43.5% suggested in
[11], from which a T1blood of 1650 ms at 3 T had been calcu-
lated. South Asian men had a mean Hct of 42.0% (3.6), lower
than either white European (43.8% (3.4)) or African
Caribbean men (43.0% (3.5)). Both South Asian (38.8%
(3.1)) and African Caribbean women (38.8% (2.4)) had lower
mean Hct than white European women (40.6% (3.0)) (Fig. 1).
Age was not associated with Hct (r = 0.06, p = 0.2).
Cerebral blood flow
Table 2 shows the results for CBFfixed and CBFHct models
stratified by sex, ethnicity and diabetes. As a result of correc-
tion for individually measured Hct when calculating T1blood,
CBFHct values were lower than CBFfixed values in all catego-
ries of sex and ethnicity except for white European and
African Caribbean men (Fig. 2).
Figure 3 demonstrates the inverse linear relationship of Hct
with CBFfixed and CBFHct models. This relationship is attenuated
with the use of the CBFHct model although some association of
Table 1 Participant characteristics
Sex Ethnicity
N All Men Women White European South Asian African Caribbean
Sex, n (female) 493 493 (196) 297 196 226 (78) 175 (67) 92 (51)**
Age, years 493 71.6 ± 5.9 72.9 ± 5.2 69.7 ± 6.4** 72.1 ± 5.8 70.8 ± 5.6** 72.0 ± 6.7
Diabetes (yes), n (%) 493 133 (27) 80 (27) 53 (27) 39 (17) 65(37) 29 (32)**
HbA1c (mmol/mol) 486 41.7 ± 9.2 41.2 ± 8.3 42.5 ± 10.3 39.2 ± 7.9 43.9 ± 8.8** 43.6 ± 11.0**
BMI (kg/m2) 489 27.5 ± 4.2 27.1 ± 3.8 28.2 ± 4.8** 27.5 ± 4.1 26.4 ± 3.7** 29.6 ± 4.7**
Haematocrit (% ) 493 41.6 ± 3.7 43.0 ± 3.5 39.5 ± 3.0** 42.7 ± 3.6 40.8 ± 3.7** 40.7 ± 3.4**
Total cholesterol (mmol/L) 492 4.7 ± 1.1 4.5 ± 1.0 5.1 ± 1.1** 4.8 ± 1.1 4.5 ± 1.0** 4.8 ± 1.1
LDL (mmol/L) 492 2.5 ± 0.9 2.4 ± 0.9 2.7 ± 0.9** 2.6 ± 0.9 2.3 ± 0.9** 2.5 ± 1.0
HDL (mmol/L) 492 1.60 ± 0.5 1.5 ± 0.4 1.8 ± 0.5* 1.6 ± 0.5 1.5 ± 0.4** 1.8 ± 0.6**
Diastolic BP (mmHg) 480 79.6 ± 8.3 79.6 ± 8.4 79.4 ± 8.0 79.7 ± 8.0 78.6 ± 7.8 80.9 ± 9.5
Heart rate (min−1) 481 64.1 ± 11.1 62.4 ± 10.9 66.7 ± 10.9** 64.5 ± 10.8 63.4 ± 11.0 64.7 ± 12.1
Mean arterial pressure (mmHg) 480 97.0 ± 10.0 97.0 ± 10.0 96.9 ± 10.0 96.7 ± 10.1 96.4 ± 9.9 98.6 ± 10.0
Anti-hypertensive medications, (yes) n (%) 493 283 (57) 183 (62) 100 (51)** 101 (45) 119 (68)** 63 (69)**
Lipid lowering medications, n (%) 493 238 (48) 138 (47) 100 (51) 120 (53) 64 (37)** 54 (59)
Data are mean ± standard deviation or number of observations (n) (%). *p < 0.05, **p < 0.01 compared to reference (male/white Europeans) by Fisher’s
LSD test after two-way analysis of variance (ANOVA)
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Hct with CBF in men remained (r= − 0.18, p = 0.002). Further
adjustment for potential confounders of mean arterial blood pres-
sure, BMI, diabetes and dyslipidemia did not affect this relation-
ship when entered in a regression model (β = − 0.3, CI − 0.6,
− 0.05 mL/100 g/min, p = 0.020) (Supp Table 2). (Note: model 2
has fewer subjects due to missing cardiovascular data.)
Introduction of individualised Hct into CBF estimation al-
tered the distributions of cortical CBF values in this elderly
population for all ethnicities (Fig. 4). The mean perfusion
difference betweenmodels was greater for women in all ethnic
categories than for men, with a mean decrease for women of
2.7 mL/100 g/min (5.4% of the CBFfixed value) (t = 17.1; CI
3.0, 2.4 mL/100 g/min; p < 0.001, d = 0.38). The perfusion
difference for African Caribbean women was − 3.1 mL/
100 g/min (6.5% decrease from the CBFfixed value) (t = 10.4;
CI − 3.6, − 2.5 mL/100 g/min; p < 0.001, d = 0.48), and for
South Asian women, it was − 3.0 mL/100 g/min (6.2% de-
crease from the CBFfixed value) (t = 10.9; CI − 3.6, − 2.5 mL/
100 g/min; p < 0.001, d = 0.56). South Asian men were the
Fig. 1 Boxplot showing median, interquartile range, upper and lower
adjacent values and outside values for haematocrit (%) by sex and
ethnicity. ** = p < 0.01 by two-way analysis of variance followed by
Fisher’s least significant difference test
Table 2 Comparison of cerebral blood flow without correction for individual haematocrit (CBF_fixed) and cerebral blood flow with correction for
individual hemtocrit (CBF_Hct) by sex, ethnicity and diabetes diagnosis
CBF_fixed
(mL/100 g/min)
CBF_Hct
(mL/100 g/min)
Difference (mL/100 g/min) Mean difference (%) p value Effect size
N Mean SD Mean SD Mean (95% CI) Mean d
All 493 50.1 ± 7.9 48.8 ± 7.3 − 1.3 (− 1.5, −1.1) − 2.6 < 0.001 0.17
Men 297 50.0 ± 8.3 49.6 ± 7.6 − 0.4 (− 0.7, −0.1) − 0.8 0.005 0.05
Women 196 50.2 ± 7.2 47.5 ± 6.8 − 2.7 (− 3.0, − 2.4) − 5.4 < 0.001 0.38
White European All 226 51.8 ± 8.3 51.1 ± 7.5 − 0.7 (− 1.0, − 0.4) − 1.4 < 0.001 0.09
Men 148 51.1 ± 8.6 51.1 ± 7.7 0.0 (− 0.5, 0.4) 0.0 0.9 0.00
Women 78 53.2 ± 7.6 51.1 ± 7.0 − 2.1 (− 2.6, − 1.6) − 4.0 < 0.001 0.29
South Asian All 175 49.1 ± 7.3 47.3 ± 6.7 − 1.8 (− 2.2, − 1.4) − 3.7 < 0.001 0.26
Men 108 49.4 ± 8.1 48.4 ± 7.3 − 1.0 (− 1.5, – 0.6) − 2.0 < 0.001 0.14
Women 67 48.7 ± 5.8 45.7 ± 5.0 − 3.0 (− 3.6, − 2.5) − 6.2 < 0.001 0.56
African Caribbean All 92 47.6 ± 6.7 45.8 ± 6.3 − 1.8 (− 2.3, − 1.3) − 3.8 < 0.001 0.29
Men 41 47.7 ± 7.0 47.4 ± 6.4 − 0.3 (− 0.9, 0.3) − 0.6 0.3 0.04
Women 51 47.6 ± 6.6 44.5 ± 6.0 − 3.1 (− 3.6,-2.5) − 6.5 < 0.001 0.48
Without diabetes 377 50.5 ± 7.8 49.4 ± 7.2 − 1.1 (− 1.4,-0.8) − 2.2 < 0.001 0.15
With diabetes 116 49.0 ± 8.3 47.2 ± 7.5 − 1.8 (− 2.3, − 1.4) − 3.7 < 0.001 0.23
Data are mean ± standard deviation, except difference (95% confidence interval CI), mean difference (%). p values were calculated using a Student’s t
test. Effect size is Cohen’s d
Fig. 2 Boxplot showing median, interquartile range, upper and lower
adjacent values and outside values for cerebral blood flow without
correction for individual haematocrit (CBFfixed) and cerebral blood flow
with correction for individual haematocrit (CBFHct) by sex and ethnicity.
* = p < 0.05, ** = p < 0.01 by two-way analysis of variance followed by
Fisher’s least significant difference test
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only male category displaying a significant difference between
models with a perfusion difference of − 1.0 mL/100 g/min
(2.0% decrease from the CBFfixed value) (t = 4.3; CI − 1.5,
− 2.0 mL/100 g/min; p < 0.001, d = 0.14). Figure 5 pro-
vides an example of CBF maps illustrating the decrease in
CBF estimation of a female subject with an Hct of 37.3%.
The application of PVC removed most of the negative as-
sociation of CBF with age in both models (CBFfixed, r =
− 0.02, p = 0.7; CBFHct, r = 0.00, p = 0.2). Adjustment for Hct
did not significantly alter this relationship.
Diabetes
People with diabetes had a mean (SD) Hct of 40.7% (4.1)
compared with 42.0% (3.5) for those without diabetes. The
perfusion difference between CBF models of people with di-
abetes was − 1.8 mL/100 g/min (3.7% of the CBFfixed value)
(t = 7.8; CI − 2.3, − 1.4 mL/100 g/min; p < 0.001, d = 0.23),
whereas those without diabetes only displayed a difference of
− 1.1 mL/100 g/min (2.2% of the CBFfixed value) (t = 8.4; CI
− 1.4, − 0.8 mL/100 g/min, p < 0.001, d = 0.15) (Fig. 6).
Discussion
This study has shown that Hct levels differ according to sex
and ethnicity and that this influences CBF estimated from
ASL. Importantly, failure to adjust T1blood according to sex
and ethnic variation in Hct leads to a significant overestima-
tion of CBF in women and non-European populations.
Although other studies have investigated the effect of Hct on
CBF estimation with ASL in sickle cell [26] and neonatal [27]
Fig. 3 Scatterplots showing the effect of correction for individual
haematocrit on the correlation between haematocrit and cortical cerebral
blood flow in men and women. Fixed Hct (CBF_fixed) (a); individualised
Hct (CBF_Hct) (b)
Fig. 4 Kernel density (kdensity) plots of CBF without correction for individual haematocrit (CBFfixed) and CBF with correction for individual
haematocrit (CBFHct) by sex and ethnicity
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groups; this is to the best of our knowledge, the first study to
address this in a community-based elderly multi-ethnic
population.
A study by Parkes et al [28] using continuous ASL found
females had higher grey matter CBF than males by 13%. It
seems likely that failure to measure individual Hct influenced
these observations. We found a similar difference in CBF
between white European men and women (+ 9.1% for wom-
en) when neither Hct nor PVC was accounted for, but this
difference was completely abolished by correction for Hct
and PVC. Following correction for PVC and Hct, CBF was
slightly lower for women than for men in South Asian
(− 5.6%) andAfrican Caribbean (− 6.0%) ethnicities. This find-
ing is broadly aligned with an 15O PET study where gender
differences in CBF evident in younger subjects were not sig-
nificant in subjects older than 65 years [29]. It has been sug-
gested that gender differences in young subjects are due to
high oestrogen levels in females causing CBF fluctuations
during the menstrual cycle [30]. Our large elderly sample
scanned with age-appropriate parameters such as a long
PLD and with CBF calculated using individualised values is
likely to provide a more accurate reflection of true physiolog-
ical differences than studies that have used a ‘one size fits all’
protocol.
We also demonstrated that the utilisation of individually
measured Hct in the calculation of T1blood reduced the inverse
correlation between CBF and Hct. However, some association
remained in men even after adjustment for mean arterial blood
pressure, diabetes and dyslipidemia. Increased CBF is an ex-
pected response to decreases in haemoglobin (and thus Hct) as
a mechanism to sustain the cerebral metabolic rate of oxygen
levels (CMRO2) as demonstrated by Ibaraki et al [31]. It has
also been suggested that higher Hct levels and concomitant
increases in blood viscosity may influence capillary flow due
to alterations in functional shunting [32]. The higher Hct
levels found in men may provide an explanation why we
found some association between Hct and CBF only in men
as increasing Hct increases blood viscosity in a non-linear
relationship, and it has been suggested that increased viscosity
decreases CBF [33].
Fig. 6 Boxplot showing median, interquartile range, upper and lower
adjacent values and outside values for CBF without correction for
individual haematocrit (CBF_fixed) and CBF with correction for
individual haematocrit (CBFHct) by diabetes status. * = p < 0.05,
** = p < 0.01 by Student’s t test
Fig. 5 CBF maps overlaid on
segmented T1w without and with
adjustment for measured
haematocrit. The subject was a
white European woman with an
haematocrit of 37.3%
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Lower values of Hct in those with diabetes indicate that
further investigation using larger samples is warranted to in-
vestigate the interactions of sex, ethnicity, Hct and the effect of
diabetes on CBF.
Investigation of the association of age and CBF, which had
yielded conflicting evidence in previous studies [10, 28, 34], was
not the main aim of our study. However, it is noteworthy that we
found an association between age and CBF in the non-partial
volume-corrected data which disappeared following partial vol-
ume correction. A likely explanation for this is the decreased
brain volume in older subjects which makes the ASL perfusion
datamore prone to partial volume effects with non-perfusedCSF,
thereby leading to an artificial CBF decrease. However, PVC
may introduce overestimation of cortical CBF particularly in
examinations hampered by head movement or poor SNR, either
in the T1 structural images used for segmentation or in the ASL
acquisition which as a subtraction technique is particularly sus-
ceptible to movement artefact. Some movement inevitably re-
mains in a large population study of elderly individuals and this
may be a potential source of under- or overestimation of partial
volume-corrected CBF in our cohort.
Despite a more diverse ethnic sample, our cortical grey matter
CBF values are comparable with previous studies using PCASL
on elderly, community-dwelling populations [6, 7]. PCASL has
some limitations when applied to elderly subjects. One factor
affecting CBF quantification is blood velocity relative to the
labelling plane. Any discrepancies from the expected range of
blood velocities due to vascular pathologies such as internal ca-
rotid stenosis or vessel tortuositymight result in reduced labelling
efficiency and therefore CBF underestimation. Our study used
2D PCASL, rather than a 3D technique, which may be liable to
decreased SNR due to longer T1 blood relaxation in slices near
the vertex due to sequential slice acquisition [35], despite using
slice-timing correction. Inefficiency of background suppression
pulses during multiple slice acquisitions may also have affected
the ASL signal.
The main strength of this study was its large community-
based, elderly, ethnically diverse sample studied in a single centre
so that all protocols were consistently applied throughout.
Limitations of the study include a potential selection bias towards
healthy individuals who were willing and able to attend the re-
search clinic. Another limitationwas the absence of direct T1blood
measurements, although this was mitigated by the use of a pre-
viously publishedmodel to account for the effect of Hct [13]. Hct
is the main determinant of T1blood, but other factors such as
serum ferritin and HDL cholesterol may also contribute to a
minor extent [36]. Measurement of arterial rather than venous
Hct would have been more appropriate to estimate CBF.
However, measuring arterial Hct in clinic was impractical and
it was considered that venous and arterial Hct were closely relat-
ed and importantly that venous Hct could be sampled consistent-
ly [37]. Although T1blood can be easily directly measured in the
left ventricle and has lower test-retest variability compared with
measured Hct [38], comparable sequences in the brain are more
challenging due to partial volume effects, blood velocity and
pulsatility in the measured vessel [27, 39].
Our findings suggest that research studies using ASL to mea-
sure CBF should routinely measure Hct to adjust T1blood, espe-
cially in inhomogenous samples. Alternatively, substitution of an
appropriate gender- and ethnicity-specificHct value derived from
population group means or direct measurement of T1blood during
MRI would improve accuracy of CBF measurement. Further
research is warranted into whether adjustment to the Hct value
in CBF models to accommodate demographic and pathological
differences provides stronger associations with cerebrovascular
disease, dementia and cognitive decline than previous models
using a fixed mean Hct value. Results from previous studies
may need to be interpreted with caution where there are ethnic,
gender and pathological differences in the sample. Such an ap-
proach may improve early risk assessment in ethnic groups and
identify potentially vulnerable groups such as those with known
vascular or metabolic disease.
In conclusion, we demonstrated that CBF values obtained
from ASL using a fixed Hct mean may lead to systematic errors,
resulting most frequently in an overestimation of CBF in female
subjects and non-Caucasian ethnicities. It is important to be
aware of this when using CBF threshold values to assess disease
status or severity. This applies not only to the discrimination
between normal ageing and a neurogenerative disease such as
AD but could potentially also influence the discrimination be-
tween high- and low-grade brain tumours or determination of
penumbral threshold values in stroke. We therefore argue that
whenever possible, individualised measures of Hct should be
included in CBF calculations by ASL.
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